Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction
Trinity J. Bivalacqua(University of Pennsylvania), Philip J. Kadowitz(University of Iowa), Subramanyam N. Murthy(Tulane University), Wayne J.G. Hellstrom(Tulane University), Bradley K. Taylor(University of Pittsburgh), Muammer Kendirci(Tulane University), Hunter C. Champion(Southeastern University), Mustafa F. Usta(Augusta University), Weiwen Deng(Tulane University), Christine Robinson(Tulane University)
American Journal of Physiology-Heart and Circulatory Physiology
October 28, 2006
Cited by 149
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Priapism: Pathogenesis, Epidemiology, and Management
|The Journal of Sexual Medicine|2010|401
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction
|Proceedings of the National Academy of Sciences|2004|316
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|European Urology|2014|297